Benign prostatic hyperplasia–what do we know?

CM Devlin, MS Simms, NJ Maitland - BJU international, 2021 - Wiley Online Library
Objectives To present historical and contemporary hypotheses on the pathogenesis of
benign prostatic hyperplasia (BPH), and the potential implications for current medical …

The role of the prostate in male fertility, health and disease

P Verze, T Cai, S Lorenzetti - Nature Reviews Urology, 2016 - nature.com
Ejaculation is a synchronized cascade of events that has the ultimate goal of activating
sperm and enabling them to reach an egg for fertilization. The seminal plasma contains a …

[HTML][HTML] Prostate diseases and microbiome in the prostate, gut, and urine

M Miyake, Y Tatsumi, K Ohnishi, T Fujii, Y Nakai… - Prostate …, 2022 - Elsevier
The microbiome in various organs involves a vast network that plays a key role in the health
and wellness of the human body. With recent advances in biological technologies such as …

Male bladder microbiome relates to lower urinary tract symptoms

P Bajic, ME Van Kuiken, BK Burge… - European urology …, 2020 - Elsevier
Background In women, compelling evidence associates lower urinary tract microbiota
(LUTM) with lower urinary tract symptoms (LUTS); a similar association in men with benign …

Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia

C De Nunzio, A Salonia, M Gacci, V Ficarra - World journal of urology, 2020 - Springer
Purpose To review the role of a persistent prostatic inflammatory status (PIS) in the
development and progression of benign prostatic hyperplasia (BPH) associated with lower …

A novel insight into the immune-related interaction of inflammatory cytokines in Benign prostatic hyperplasia

X Naiyila, J Li, Y Huang, B Chen, M Zhu, J Li… - Journal of Clinical …, 2023 - mdpi.com
Benign prostatic hyperplasia (BPH) is a common male condition that impacts many men's
quality of life by generating lower urinary tract symptoms (LUTS). In recent years …

Efficacy and safety of hexanic lipidosterolic extract of Serenoa repens (Permixon) in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia …

G Novara, G Giannarini, A Alcaraz, JM Cozar-Olmo… - European urology …, 2016 - Elsevier
Abstract Context A recent Cochrane Collaboration meta-analysis of randomized controlled
trials (RCTs) evaluating the efficacy of different extracts of Serenoa repens in relieving lower …

Effects of hexanic extract of serenoa repens (permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign …

A Latil, MT Pétrissans, J Rouquet, G Robert… - The …, 2015 - Wiley Online Library
Background Chronic prostatic inflammation (CPI) could be a cause of symptomatic or
complicated benign prostatic hyperplasia (BPH). In previous in vitro and in vivo studies …

Review of the roles and interaction of androgen and inflammation in benign prostatic hyperplasia

Y Tong, R Zhou - Mediators of Inflammation, 2020 - Wiley Online Library
The lower urinary tract symptoms (LUTSs) and acute urinary retention (AUR) caused by
benign prostatic hyperplasia (BPH) can seriously affect the quality of life of elderly men …

The role of prostatic inflammation in the development and progression of benign and malignant diseases

G Gandaglia, E Zaffuto, N Fossati… - Current opinion in …, 2017 - journals.lww.com
Men with BPH-related lower urinary tract symptoms and chronic prostatic inflammation
should be considered at increased risk of symptom progression and acute urinary retention …